A Combined Mindfulness-diving Protocol on Emotional Eating in Obese Patients: a Prospective Randomized Study (OBEDIVE)

March 12, 2025 updated by: BATHYSMED

Benefit of the Bathysmed® Diving Protocol on Emotional Eating in Obese Patients: a Prospective Randomized Study

The goal of this clinical trial is to learn if a combined minfulness-diving program has an impact on emotional eating in adults with obesity. The main questions it aims to answer are:

Does the BathysMed protocol have an impact on emotional eating after the 2 months diving protocol? Researchers will compare the diving program to a control group of adult patients with obesity.

Participants will be asked to participate in the combined mindfulness-diving protocol for 2 months, and complete the questionnaires at baseline, 2, 5, and 8 months follow up.

Study Overview

Detailed Description

This unblinded randomized controlled trial is performed in the community setting, Montpellier, France. Adults with a BMI > 30kg/m2 were randomly assigned (1:1) to a Bathysmed® 2-month program (intervention group) therapeutic scuba-diving protocol with mindfulness exercises plus standard care, or stand-alone standard care including dietary and psychological support (control group). The primary outcome was the mean change in the emotional eating subscale of the Dutch Eating Behaviour Questionnaire (DEBQ-EE) at 2-months as intention to treat.

Study Type

Interventional

Enrollment (Actual)

63

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Montpellier, France, 34080
        • BathysMed

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • patients with obesity (Body Mass Index BMI > 30kg/m2),
  • adults over the age of 18 able to provide written consent
  • affiliated to public medical insurance.

Exclusion Criteria:

  • BMI > 45 kg/m2,
  • older than 60 years,
  • unable to walk,
  • known psychiatric pathology apart from anxiety and depression,
  • intellectual deficit,
  • routinely practising meditation,
  • a known contra-indication to scuba-diving
  • known past medical history of cardiac problems.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Diving group
The program included ten scuba-diving sessions with mindfulness training, twice a week for five weeks, alongside standard care for obesity in a primary care centre in Montpellier
The Bathysmed program is a unique scuba diving program that combines scuba immersion with techniques from mindfulness meditation, psychology and sports mental preparation. The program includes 30 different exercises over ten scuba-diving sessions with mindfulness training, twice a week for five weeks.
Other Names:
  • BathysMed Diving protocol
Placebo Comparator: Control group
Standard care included regular appointments and health education with their general practitioner and monthly appointments with the dietician and psychotherapist at the primary care centre in Montpellier, France throughout the study.
Standard care includes regular appointments and health education with their general practitioner and monthly appointments with the dietician and psychotherapist at the primary care centre in Montpellier, France throughout the study. This care includes monthly sessions on diet, exercise and general stress management with a registered dietician.
Other Names:
  • Control group

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
DEBQ-EE
Time Frame: 2 months
The primary outcome was the mean change in the emotional eating subscale of the Dutch Eating Behaviour Questionnaire (DEBQ-EE) at the end of the two-month protocol.
2 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
DEBQ-EE at 5 and 8 months follow up
Time Frame: 5 and 8 months follow up
emotional eating subscale of the Dutch Eating Behaviour Questionnaire (DEBQ-EE) at 5 and 8 months follow up
5 and 8 months follow up
DEBQ-RE
Time Frame: 2, 5 and 8 months follow up
Change in the Restrictive eating subscale of the Dutch Eating Behaviour Questionnaire (DEBQ-EE) between baseline and two, five and eight months follow up
2, 5 and 8 months follow up
DEBQ-ExtE
Time Frame: 2, 5 and 8 months follow up
Change in the external eating subscale of the Dutch Eating Behaviour Questionnaire (DEBQ-EE) between baseline two, five and eight months follow up
2, 5 and 8 months follow up
WSSQ
Time Frame: 2, 5 and 8 months follow up
Change in weight bias internalisation (WBI) and weight self-stigma using the Weight Self Stigma Questionnaire (WSSQ), score between baseline and 2, 5 and 8 months follow up
2, 5 and 8 months follow up
EQVOD scale
Time Frame: 2, 5 and 8 months follow up
Change in the quality of life using a specific questionnaire for obese patients EQVOD (l'échelle de Qualité de Vie Obésité et Diététique) (17); between baseline and 2 , 5 and 8 months follow up
2, 5 and 8 months follow up
PSS Score
Time Frame: 2, 5 and 8 months follow up
Evaluation of Perceived Stress Scale of Cohen score (PSS), between baseline and 2, 5 and 8 months follow up
2, 5 and 8 months follow up
Weight (kg)
Time Frame: 2, 5 and 8 months follow up
Weight measured in Kg
2, 5 and 8 months follow up
BMI kg/m2
Time Frame: 2, 5 and 8 months follow up
BMI kg/m2 Body Mass Index
2, 5 and 8 months follow up
Waist circumference
Time Frame: 2, 5 and 8 months follow up
Waist circumference (cm)
2, 5 and 8 months follow up

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 1, 2022

Primary Completion (Actual)

November 1, 2022

Study Completion (Actual)

April 30, 2023

Study Registration Dates

First Submitted

March 12, 2025

First Submitted That Met QC Criteria

March 12, 2025

First Posted (Actual)

March 25, 2025

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

March 12, 2025

Last Verified

March 1, 2025

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • BTY-2022-05-OBEDIVE
  • 4021591/1 (Other Grant/Funding Number: BPI France)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Obesity and Overweight

Clinical Trials on A combined mindfulness and therapeutic scuba-diving protocol

Subscribe